 |
Search "Intron"
|
|
Intron | |
|
About 8 pages (2,327 words) in 3 products |
|
Encyclopedia and Summary Information
 summary from source:
 Exons and Introns Summary
517 words, approx. 2 pages Exons and introns refer to specific nucleotide base sequences in the genetic code that are involved in producing proteins. Exons are the DNA bases that are transcribed into mRNA and eventually code for amino acids in the proteins. Introns are DNA... summary from source:
 Exons and Introns Summary
512 words, approx. 2 pagesExons and introns refer to specific nucleotide base sequences in the genetic code that are involved in producing proteins. Exons are the DNA bases that are transcribed into mRNA and eventually code for amino acids in the proteins. Introns are DNA bases... summary from source:
 Intron Information
1,298 words, approx. 4 pages
Introns, derived from the term "intragenic regions", are non-coding sections of DNA or precursor mRNA (hnRNA). Once a DNA sequence has been transcribed as a hnRNA strand, the introns will be spliced out. The resulting mRNA sequence will then be... 
 summary from source:
 OB GYN News PEG-Intron.
03/15/2001: 432 words, approx. 1 pages (peginterferon alfa-2b, Schering-Plough Corp.) A long-acting formulation of Intron A (interferon alfa-2b) for once-weekly monotherapy in patients with chronic hepatitis C who were not previously treated with alpha-interferon, have compensated liver disease, and are at least age 18 years. This is the first... summary from source:
OB GYN News PEG-Intron and Rebetol.
09/15/2001: 429 words, approx. 1 pages (peginterferon alfa-2b and ribavirin, Schering-Plough Corp.) A long-acting formulation of Intron-A (interferon alfa-2b) with the antiviral Rebetol, for people aged 18 and over who have chronic hepatitis C infections with compensated liver disease, and who have not been treated previously with alfa-interferon. This... summary from source:
 AP Features summary from source:
AP News Schering-Plough 4Q profit up 75 percent
1/29/2007: 519 words, approx. 2 pagesThe Drugmaker Schering-Plough Corp. said Monday its fourth-quarter profit surged 75 percent as strong sales of its cholesterol, arthritis and medicines helped offset rising costs.Kenilworth, N.J.-based Schering-Plough said net income totaled $182 million, or 12 cents per share, up from $104 million, or 7 cents...
|
Intron | |
|
About 8 pages (2,327 words) in 3 products |
|
|
|
|
| |
|
| |
